Barium-137: A Strategic Step for ASP Isotopes
ASP Isotopes Inc. (ASPI) is expanding into one of the most critical frontiers of the quantum computing supply chain: Barium-137 (Ba-137).
Why Ba-137 Matters
Ba-137 is a stable isotope used in ion-trap quantum computers, one of the most promising architectures for scalable, fault-tolerant quantum systems. Its unique properties give it longer “coherence times” (how long a qubit can hold information) and higher reliability than many alternatives, making it a key ingredient in powering the next generation of quantum processors.
ASPI’s Advantage
- First Commercial Order Secured – ASPI received a purchase order in September 2025, with deliveries starting in Q1 2026.
- Proven Technology – This validates their Quantum Laser Enrichment (QLE) process for heavy isotopes, positioning ASPI as one of the only Western-aligned suppliers at a time when most stable isotope supply has historically come from Russia.
- Attractive Economics – Pricing for Ba-137 is estimated at $500 – $1,000 per gram, with demand projected to grow sharply as ion-trap systems scale.
Market Opportunity
- The global stable isotope market is projected to grow from $2 billion in 2025 to $14+ billion by 2034.
- Quantum computing demand alone is expected to expand at 30-40% CAGR, creating a supply gap that ASPI is uniquely positioned to fill.
- Today, less than 100 kg of Ba-137 is available worldwide each year. By 2026, ASPI plans to bring 1-5 kg to market, scaling to 20+ kg by 2027.
The Supply Chain Risk
For all its potential, Ba-137 faces a major hurdle: supply chain fragility. Global enrichment capacity is under 100 kg annually, with the vast majority still tied to Russian facilities. Sanctions and geopolitical tensions have created 6–12 month lead times and cost spikes of 20–50%. With no commercial-scale U.S. alternative, quantum computing programs risk severe delays if these bottlenecks persist.
This is where ASPI’s QLE technology makes a difference. Its modular plants can be deployed 10–20x faster than legacy systems, enabling rapid domestic production that both secures supply and reduces reliance on sanctioned or aging facilities abroad.
Risks: Delays cap low-end; reshoring boosts high-end.
Competitor Breakdown
Few suppliers offer quantum-grade Ba-137 (>99.9% purity). ASPI’s QLE provides a scalable edge over centrifuge-based methods.
ASPI holds first-mover in laser enrichment.
Why It’s Strategic
Barium-137 isn’t just another isotope, it’s a strategic asset. By securing supply now, ASPI is:
- De-risking the U.S. supply chain by reducing reliance on sanctioned or aging foreign facilities.
- Positioning in quantum computing – a field expected to transform industries from healthcare to cryptography.
- Capturing first-mover advantage in a market with limited supply and rising demand.
The Bigger Picture
ASPI’s ability to rapidly deploy enrichment capacity, 10–20x faster than legacy systems, gives it an edge in closing critical isotope supply gaps. For quantum innovators, Ba-137 could prove to be the isotope that unlocks commercial-scale systems. And for ASPI, it’s another proof point that they’re not just keeping up with global demand, they’re leading it.
